| 76 |
218492 |
Prucalopride Tablets |
Novitium Pharma LLC |
Motegrity Tablets |
12/26/2024 |
For the treatment of chronic idiopathic constipation in adults |
| 75 |
215971 |
Deutetrabenazine Tablets |
Aurobindo Pharma Limited |
Austedo Tablets |
12/26/2024 |
For the treatment in adults of Chorea associated with Huntington’s disease. |
| 74 |
215503 |
Liraglutide Injection |
Hikma Pharmaceuticals USA, Inc |
Victoza Injection |
12/23/2024 |
An adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus |
| 73 |
217227 |
Tetracaine Hydrochloride Ophthalmic Solution USP, |
Somerset Therapeutics, LLC |
Tetracaine Hydrochloride Ophthalmic Solution USP, |
12/20/2024 |
For procedures requiring a rapid and short-acting topical ophthalmic anesthetic |
| 72 |
203540 |
Raltegravir Tablets USP |
Hetero Labs Limited, Unit III |
Isentress Tablets |
12/19/2024 |
Indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult patients |
| 71 |
213637 |
Iobenguane I 123 Injection USP |
BWXT Medical Ltd |
AdreView Injection |
12/9/2024 |
Use in the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests |
| 70 |
214445 |
Baclofen Oral Solution |
Rubicon Research Private Limited |
Ozobax Oral Solution |
12/6/2024 |
For the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity |
| 69 |
216608 |
Aripiprazole for Extended-Release Injectable Suspension |
Mylan Pharmaceuticals Inc. |
Abilify Maintena for Extended-Release Injectable Suspension |
12/3/2024 |
For the treatment of schizophrenia in adults. |
| 68 |
213708 |
Epinephrine Injection USP |
Fresenius Kabi USA, LLC |
Epinephrine Injection USP |
11/20/2024 |
To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock |
| 67 |
206697 |
Exenatide Injection USP |
Amneal EU, Limited |
Byetta Injection |
11/19/2024 |
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. |
| 66 |
218538 |
Chromic Chloride Injection USP |
Stira Pharmaceuticals LLC |
Chromic Chloride Injection USP |
11/18/2024 |
For use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). |
| 65 |
217887 |
Ciprofloxacin Otic Solution |
IdentiRx, LLC |
Cetraxal Otic Solution |
11/5/2024 |
For the treatment of acute otitis externa due to susceptible isolates of Pseudomonas aeruginosa or Staphylococcus aureus |
| 64 |
217795 |
Topiramate Oral Solution |
Alkem Laboratories Limited |
Eprontia Oral Solution, |
10/31/2024 |
For the treatment of Epilepsy: Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. |
| 63 |
216783 |
Cyclophosphamide Injection |
Nexus Pharmaceuticals, LLC |
Cyclophosphamide Injection |
10/29/2024 |
For the treatment of Malignant Diseases: malignant lymphomas: Hodgkin’s disease, lymphocytic lymphoma, mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma; multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of ovary, retinoblastoma, breast carcinoma |
| 62 |
214934 |
Minocycline for Injection |
Nexus Pharmaceuticals, LLC |
Minocin for Injection |
10/24/2024 |
The treatment of infections due to susceptible isolates of the designated bacteria. |
| 61 |
217721 |
Ephedrine Sulfate Injection |
Hikma Pharmaceuticals USA, Inc. |
Akovaz Injection |
10/11/2024 |
For the treatment of clinically important hypotension occurring in the setting of anesthesia. |
| 60 |
212700 |
Paclitaxel |
Jiangsu Hengrui Pharmaceuticals Co., Ltd |
Abraxane for Injectable Suspension |
10/8/2024 |
Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy |
| 59 |
215488 |
Methohexital Sodium for Injection |
Onesource Specialty Pte. Limited |
Brevital |
10/3/2024 |
For intravenous induction of anesthesia prior to the use of other general anesthetic agents. |
| 58 |
216936 |
Drospirenone Tablets |
Lupin Limited |
Slynd |
9/30/2024 |
For use by females of reproductive potential to prevent pregnancy |
| 57 |
218112 |
Dexmedetomidine Injection USP |
Somerset Therapeutics, LLC |
Dexmedetomidine Injection |
9/24/2024 |
For the sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting; for them edation of non-intubated patients prior to and/or during surgical and other procedures |
| 56 |
215592 |
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection |
Cipla Limited |
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection |
9/24/2024 |
For the short-term treatment of hypertension when oral therapy is not feasible |
| 55 |
208112 |
Methylnaltrexone Bromide Injection |
Actavis LLC |
Relistor Injection |
8/26/2024 |
For the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain; for the treatment of OIC in adults with advanced illness or pain caused by active cancer who require opioid dosage escalation for palliative care |
| 54 |
214897 |
Amantadine Extended-Release Capsules |
Zydus Worldwide DMCC |
Gocovri Extended-Release Capsules |
8/26/2024 |
For the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications |
| 53 |
216035 |
Riluzole Oral Suspension |
Alkem Laboratories Limited |
Tiglutik Oral Suspension |
8/22/2024 |
For the treatment of amyotrophic lateral sclerosis (ALS) |
| 52 |
218613 |
Lofexidine Tablets |
Indoco Remedies Limited |
Lucemyra Tablets |
8/20/2024 |
For the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults |
| 51 |
216137 |
Valbenazine Capsules |
Zydus Worldwide DMCC |
Ingrezza Capsules |
8/7/2024 |
For the treatment of adults with tardive dyskinesia |
| 50 |
219002 |
Trametinib Tablets |
Novugen Oncology Sdn. Bhd. |
Mekinist Tablets |
8/6/2024 |
For the treatment of patients with melanoma with BRAF V600E or V600K mutations; patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation; patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation; adult and pediatric patients 1 year of age and older with unresectable or metastatic solid tumors with BRAF V600E mutation; pediatric patients 1 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation |
| 49 |
216935 |
Prednisolone Acetate Ophthalmic Suspension USP |
Lupin Limited |
Pred Forte Ophthalmic Suspension |
8/2/2024 |
Reduces the irritation, redness, burning, and swelling of eye inflammation caused by chemicals, heat, radiation, infection, allergy, or foreign bodies in the eye |
| 48 |
216021 |
Pantoprazole Sodium for Injection |
Fresenius Kabi USA, LLC |
Pantoprazole Sodium for Injection |
8/1/2024 |
For the short-term treatment (7 to 10 days) of gastroesophageal reflux disease (GERD) associated with a history of erosive esophagitis (EE); for the treatment of pathological hypersecretion conditions, including Zollinger-Ellison (ZE) syndrome |
| 47 |
217542 |
Baricitinib Tablets |
Aurobindo Pharma USA, Inc. |
Olumiant Tablets |
7/22/2024 |
“the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF blockers” |
| 46 |
217075 |
Tazarotene Cream |
Padagis Israel Pharmaceuticals Ltd |
Tazorac Cream |
7/15/2024 |
Indicated as an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs |
| 45 |
216937 |
Nimodipine Oral Solution |
Annora Pharma Private Limited |
Nymalize Oral Solution |
7/9/2024 |
For the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage |
| 44 |
215647 |
L-Glutamine Oral Powder |
Novitium Pharma LLC |
Endari Oral Powder |
7/8/2024 |
To reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older |
| 43 |
212785 |
Indium In-111 Pentetreotide Kit for Injection |
Sun Pharmaceutical Industries, Inc. |
Octreoscan |
7/2/2024 |
For the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors |
| 42 |
214348 |
Bupivacaine Liposome Injectable Suspension |
Jiangsu Hengrui Pharmaceuticals Co., Ltd |
Exparel Injectable Suspension |
7/1/2024 |
Indicated to produce postsurgical local analgesia via infiltration in adults; regional analgesia via an interscalene brachial plexus nerve block in adults |
| 41 |
204982 |
Phentermine and Topiramate Extended-release Capsules |
Actavis Laboratories FL, Inc. |
Qsymia Extended-release Capsule |
6/25/2024 |
Indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in certain adult and pediatric patients |
| 40 |
213688 |
0.9% Sodium Chloride Irrigation USP |
Fresenius Kabi USA, LLC |
Sodium Chloride Injection |
6/24/2024 |
For all general irrigation, washing, rinsing, dilution purposes which permit use of a sterile, non-pyrogenic electrolyte solution |
| 39 |
209266 |
Avanafil Tablets |
Hetero Labs Limited Unit V |
Stendra Tablets |
6/14/2024 |
For the treatment of erectile dysfunction |
| 38 |
215570 |
Palbociclib Tablets |
Synthon Pharmaceuticals, Inc |
Ibrance Tablets |
6/2/2024 |
For the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy or fulvestrant in patients with disease progression following endocrine therapy |
| 37 |
217671 |
Halcinonide Topical Solution USP |
Encube Ethicals Private Limited |
Halog Topical Solution |
5/29/2024 |
For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses |
| 36 |
216421 |
Azelastine Hydrochloride Nasal Spray |
Apotex Inc. |
Astepro Nasal Spray |
5/29/2024 |
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies |
| 35 |
213682 |
Sacubitril and Valsartan Tablets |
Alembic Pharmaceuticals Limited |
Entresto Tablets |
5/28/2024 |
To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure; for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older |
| 34 |
213676 |
Sacubitril and Valsartan Tablets |
Laurus Labs Limited |
Entresto Tablets |
5/28/2024 |
To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure; for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older |
| 33 |
213605 |
Sacubitril and Valsartan Tablets |
Crystal Pharmaceutical (Suzhou) Co., Ltd. |
Entresto Tablets |
5/28/2024 |
To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure; for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older |
| 32 |
216343 |
Timolol Maleate Ophthalmic Gel Forming Solution |
Amneal EU, Limited |
Timolol Maleate Ophthalmic Gel Forming Solution |
5/23/2024 |
For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma |
| 31 |
217193 |
Lanreotide Injection |
InvaGen Pharmaceuticals, Inc. |
Somatuline Depot Injection |
5/21/2024 |
For the long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy; for the treatment of adult patients with unresectable, well- or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival; for the treatment of adults with carcinoid syndrome |
| 30 |
214053 |
Emtricitabine and Tenofovir Alafenamide Tablets |
Apotex Inc. |
Descovy Tablets |
5/17/2024 |
In combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg; in combination with other antiretroviral agents other than protease inhibitors that require a CYP3A inhibitor for the treatment of HIV-1 infection in pediatric patients weighing at least 14 kg and less than 35 kg; indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) |
| 29 |
218354 |
Edaravone Injection |
Long Grove Pharmaceuticals, LLC |
Radicava Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 28 |
216199 |
Edaravone Injection |
Gland Pharma Limited |
Radicava Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 27 |
215917 |
Edaravone Injection |
Dr. Reddy’s Laboratories Limited |
Radicava Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 26 |
215508 |
Edaravone Injection |
Hikma Pharmaceuticals USA, Inc. |
Radicava Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 25 |
217791 |
Atropine Sulfate Ophthalmic Solution USP |
Somerset Therapeutics, LLC |
Isopto Atropine Ophthalmic Solution |
4/29/2024 |
Indicated for mydriasis; cycloplegia; penalization of the healthy eye in the treatment of amblyopia |
| 24 |
216076 |
Midostaurin Capsules |
Teva Pharmaceuticals Development, Inc |
Rydapt Capsules |
4/29/2024 |
For the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive; for the treatment of adult patients with aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, or mast cell leukemia |
| 23 |
217813 |
Deflazacort Oral Suspension |
Tris Pharma, Inc. |
Emflaza Oral Suspension |
4/25/2024 |
For the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older |
| 22 |
216160 |
Estradiol Gel |
Solaris Pharma Corporation |
EstroGel Gel |
4/22/2024 |
For the treatment of moderate to severe vasomotor symptoms due to menopause; for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause |
| 21 |
216620 |
Eltrombopag for Oral Suspension |
Annora Pharma Private Limited |
Promacta for Oral Suspension |
4/18/2024 |
For the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy; for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy; for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy |
| 20 |
203978 |
Nicardipine Hydrochloride in 0.83% Sodium Chloride Injection |
InfoRLife SA |
Cardene Premixed injection |
4/17/2024 |
For the short-term treatment of hypertension when oral therapy is not feasible |
| 19 |
218034 |
Doxycycline Capsules |
Dr. Reddy’s Laboratories Limited |
Oracea Capsules |
4/8/2024 |
For the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients |
| 18 |
216631 |
Doxycycline Capsules |
Lupin, Inc. |
Oracea Capsules |
4/8/2024 |
For the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients |
| 17 |
218047 |
Eribulin Mesylate Injection |
Gland Pharma Limited |
Halaven Injection |
4/5/2024 |
For the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease; unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen |
| 16 |
216064 |
Valbenazine Capsules |
Lupin Limited |
Ingrezza Capsules |
4/5/2024 |
For the treatment of adults with tardive dyskinesia |
| 15 |
216795 |
Metronidazole Vaginal Gel |
Encube Ethicals |
Nuvessa Vaginal Gel |
3/18/2024 |
For the treatment of bacterial vaginosis in females 12 years of age and older |
| 14 |
218232 |
Finasteride and Tadalafil Capsules |
Zydus Worldwide DMCC |
Entadfi Capsules |
3/15/2024 |
To initiate treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate for up to 26 weeks |
| 13 |
216361 |
Brimonidine Tartrate Ophthalmic Solution |
Dr. Reddy’s Laboratories SA |
Lumify Ophthalmic Solution |
2/16/2024 |
Relieves redness of the eye due to minor eye irritations |
| 12 |
216103 |
Nitroglycerin Ointment USP |
Dr. Reddy’s Laboratories SA |
Rectiv Ointment |
2/16/2024 |
For the treatment of moderate to severe pain associated with chronic anal fissure |
| 11 |
215574 |
Ospemifene Tablets |
Hetero Labs Limited Unit V |
Osphena Tablets |
2/13/2024 |
For the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause; for the treatment of moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy, due to menopause |
| 10 |
217123 |
Deflazacort Tablets |
Aurobindo Pharma Limited |
Emflaza Tablets |
2/9/2024 |
For the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older |
| 9 |
216899 |
Hydromorphone Hydrochloride Injection USP |
Hikma Pharmaceuticals USA, Inc. |
Dilaudid Injection |
2/9/2024 |
For the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate |
| 8 |
209986 |
Cobicistat Tablets |
Mylan Laboratories Limited |
Tybost Tablets |
2/4/2024 |
For the treatment of HIV-1 infection in adults and in pediatric patients |
| 7 |
211239 |
Bromfenac Ophthalmic Solution |
Lupin Limited |
BromSite Ophthalmic Solution |
2/2/2024 |
For the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery |
| 6 |
205904 |
Dronedarone Tablets USP |
Lupin Inc. |
Multaq Tablets |
1/31/2024 |
To reduce the risk of hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF |
| 5 |
214925 |
Pimavanserin Capsules |
MSN Laboratories Private Limited |
Nuplazid Capsules |
1/16/2024 |
For the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis |
| 4 |
214502 |
Pimavanserin Tablets |
Zydus Pharmaceuticals (USA) Inc. |
Nuplazid Capsules |
1/16/2024 |
For the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis |
| 3 |
214493 |
Pimavanserin Capsules |
Zydus Pharmaceuticals (USA) Inc. |
Nuplazid Capsules |
1/16/2024 |
For the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis |
| 2 |
208443 |
Fidaxomicin Tablets |
Actavis Laboratories FL, Inc. |
Dificid Tablets |
1/16/2024 |
For the treatment of C. difficile-associated diarrhea |
| 1 |
203640 |
Nilotinib Capsules |
Apotex, Inc. |
Tasigna Capsules |
1/5/2024 |
For the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase; adult patients with chronic phase (CP) and accelerated phase (AP) Ph+ CML resistant to or intolerant to prior therapy that included imatinib; pediatric patients greater than or equal to 1 year of age with Ph+ CML-CP and CML-AP resistant or intolerant to prior tyrosine-kinase inhibitor therapy |
| 58 |
216936 |
Drospirenone Tablets, 4 mg |
Lupin Limited |
Slynd (Drospirenone Tablets) |
9/30/2024 |
For use by females of reproductive potential to prevent pregnancy |
| 57 |
218112 |
Dexmedetomidine Injection USP, 400 mcg/4 mL (100 mcg/mL) and 1000 mcg/10 mL (100 mcg/mL) Multiple-Dose Vials |
Somerset Therapeutics, LLC |
Dexmedetomidine Injection |
9/24/2024 |
For the sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting; for them edation of non-intubated patients prior to and/or during surgical and other procedures |
| 56 |
215592 |
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection, 20 mg/200 mL (0.1 mg/mL) and 40 mg/200 mL (0.2 mg/mL), Single-Dose Containers |
Cipla Limited |
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection |
9/24/2024 |
For the short-term treatment of hypertension when oral therapy is not feasible |
| 55 |
208112 |
Methylnaltrexone Bromide Injection, 8 mg/0.4 mL and 12 mg/0.6 mL, Single-Dose Prefilled Syringes |
Actavis LLC |
Relistor (Methylnaltrexone Bromide) Injection |
8/26/2024 |
For the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain; for the treatment of OIC in adults with advanced illness or pain caused by active cancer who require opioid dosage escalation for palliative care |
| 54 |
214897 |
Amantadine Extended-Release Capsules, 68.5 mg |
Zydus Worldwide DMCC |
Gocovri (Amantadine) Extended-Release Capsules |
8/26/2024 |
For the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications |
| 53 |
216035 |
Riluzole Oral Suspension, 50 mg/10 mL (5 mg/mL) |
Alkem Laboratories Limited |
Tiglutik (Riluzole) Oral Suspension |
8/22/2024 |
For the treatment of amyotrophic lateral sclerosis (ALS) |
| 52 |
218613 |
Lofexidine Tablets, 0.18 mg |
Indoco Remedies Limited |
Lucemyra (Lofexidine) Tablets |
8/20/2024 |
For the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults |
| 51 |
216137 |
Valbenazine Capsules, 40 mg, 60 mg, and 80 mg |
Zydus Worldwide DMCC |
Ingrezza (Valbenazine) Capsules |
8/7/2024 |
For the treatment of adults with tardive dyskinesia |
| 50 |
219002 |
Trametinib Tablets, 0.5 mg and 2 mg |
Novugen Oncology Sdn. Bhd. |
Mekinist (Trametinib) Tablets |
8/6/2024 |
For the treatment of patients with melanoma with BRAF V600E or V600K mutations; patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation; patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation; adult and pediatric patients 1 year of age and older with unresectable or metastatic solid tumors with BRAF V600E mutation; pediatric patients 1 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation |
| 49 |
216935 |
Prednisolone Acetate Ophthalmic Suspension USP, 1% |
Lupin Limited |
Pred Forte (Prednisolone Acetate) Ophthalmic Suspension |
8/2/2024 |
Reduces the irritation, redness, burning, and swelling of eye inflammation caused by chemicals, heat, radiation, infection, allergy, or foreign bodies in the eye |
| 48 |
216021 |
Pantoprazole Sodium for Injection, 40 mg per Vial (Single-Dose Vial) |
Fresenius Kabi USA, LLC |
Pantoprazole Sodium for Injection |
8/1/2024 |
For the short-term treatment (7 to 10 days) of gastroesophageal reflux disease (GERD) associated with a history of erosive esophagitis (EE); for the treatment of pathological hypersecretion conditions, including Zollinger-Ellison (ZE) syndrome |
| 47 |
217542 |
Baricitinib Tablets, 1 mg, 2 mg |
Aurobindo Pharma USA, Inc. |
Olumiant (Baricitinib) Tablets |
7/22/2024 |
“the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF blockers” |
| 46 |
217075 |
Tazarotene Cream, 0.05% |
Padagis Israel Pharmaceuticals Ltd |
Tazorac (Tazarotene) Cream |
7/15/2024 |
Indicated as an adjunctive agent for use in the mitigation (palliation) of facial fine wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines in patients who use comprehensive skin care and sunlight avoidance programs |
| 45 |
216937 |
Nimodipine Oral Solution, 60 mg/20 mL (3 mg/ mL) |
Annora Pharma Private Limited |
Nymalize (Nimodipine) Oral Solution |
7/9/2024 |
For the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage |
| 44 |
215647 |
L-Glutamine Oral Powder, 5 grams/packet |
Novitium Pharma LLC |
Endari (L-Glutamine) Oral Powder |
7/8/2024 |
To reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older |
| 43 |
212785 |
Indium In-111 Pentetreotide Kit for Injection, 3 mCi/mL |
Sun Pharmaceutical Industries, Inc. |
Octreoscan (Kit for the Preparation of Indium In 111 Pentetreotide) |
7/2/2024 |
For the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors |
| 42 |
214348 |
Bupivacaine Liposome Injectable Suspension, 1.3% (133 mg/10 mL) and 1.3% (266 mg/20 mL) Single-Dose Vials |
Jiangsu Hengrui Pharmaceuticals Co., Ltd |
Exparel (Bupivacaine Liposome) Injectable Suspension |
7/1/2024 |
Indicated to produce postsurgical local analgesia via infiltration in adults; regional analgesia via an interscalene brachial plexus nerve block in adults |
| 41 |
204982 |
Phentermine and Topiramate Extended-release Capsules, 3.75 mg/23 mg, 7.5 mg/46 mg, 11.25mg /69 mg, 15 mg/92 mg |
Actavis Laboratories FL, Inc. |
Qsymia (Phentermine and Topiramate) Extended-release Capsule |
6/25/2024 |
Indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in certain adult and pediatric patients |
| 40 |
213688 |
0.9% Sodium Chloride Irrigation USP, 1,000 mL, 2,000 mL, 3,000 mL Single-Dose Containers |
Fresenius Kabi USA, LLC |
Sodium Chloride Injection 0.9% |
6/24/2024 |
For all general irrigation, washing, rinsing, dilution purposes which permit use of a sterile, non-pyrogenic electrolyte solution |
| 39 |
209266 |
Avanafil Tablets, 50 mg, 100 mg, 200 mg |
Hetero Labs Limited Unit V |
Stendra (Avanafil) Tablets |
6/14/2024 |
For the treatment of erectile dysfunction |
| 38 |
215570 |
Palbociclib Tablets, 75 mg, 100 mg, 125 mg |
Synthon Pharmaceuticals, Inc |
Ibrance (Palbociclib) Tablets |
6/2/2024 |
For the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy or fulvestrant in patients with disease progression following endocrine therapy |
| 37 |
217671 |
Halcinonide Topical Solution USP, 0.1% |
Encube Ethicals Private Limited |
Halog (Halcinonide) Topical Solution |
5/29/2024 |
For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses |
| 36 |
216421 |
Azelastine Hydrochloride Nasal Spray, 0.15% (205.5 mcg per spray) |
Apotex Inc. |
Astepro (Azelastine Hydrochloride) Nasal Spray OTC |
5/29/2024 |
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies |
| 35 |
213682 |
Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg |
Alembic Pharmaceuticals Limited |
Entresto (Sacubitril and Valsartan ) Tablets |
5/28/2024 |
To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure; for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older |
| 34 |
213676 |
Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg |
Laurus Labs Limited |
Entresto (Sacubitril and Valsartan ) Tablets |
5/28/2024 |
To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure; for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older |
| 33 |
213605 |
Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg |
Crystal Pharmaceutical (Suzhou) Co., Ltd. |
Entresto (Sacubitril and Valsartan) Tablets |
5/28/2024 |
To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure; for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older |
| 32 |
216343 |
Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% and 0.5% |
Amneal EU, Limited |
Timolol Maleate Ophthalmic Gel Forming Solution |
5/23/2024 |
For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma |
| 31 |
217193 |
Lanreotide Injection, 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL, Single-Dose |
InvaGen Pharmaceuticals, Inc. |
Somatuline Depot (Lanreotide) Injection |
5/21/2024 |
For the long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy; for the treatment of adult patients with unresectable, well- or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival; for the treatment of adults with carcinoid syndrome |
| 30 |
214053 |
Emtricitabine and Tenofovir Alafenamide Tablets, 200 mg/25 mg and 120 mg/15 mg |
Apotex Inc. |
Descovy (Emtricitabine and Tenofovir Alafenamide) Tablets |
5/17/2024 |
In combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg; in combination with other antiretroviral agents other than protease inhibitors that require a CYP3A inhibitor for the treatment of HIV-1 infection in pediatric patients weighing at least 14 kg and less than 35 kg; indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) |
| 29 |
218354 |
Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single Dose Bags |
Long Grove Pharmaceuticals, LLC |
Radicava (Edaravone) Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 28 |
216199 |
Edaravone Injection, 30 mg/100 mL (0.3 mg/mL) and 60 mg/100 mL (0.6 mg/mL), Single-Dose Bags |
Gland Pharma Limited |
Radicava (Edaravone) Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 27 |
215917 |
Edaravone Injection, 60 mg/100 mL (0.6 mg/mL), Single-Dose Bag |
Dr. Reddy’s Laboratories Limited |
Radicava (Edaravone) Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 26 |
215508 |
Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single-Dose Vials |
Hikma Pharmaceuticals USA, Inc. |
Radicava (Edaravone) Injection |
5/6/2024 |
For the treatment of amyotrophic lateral sclerosis |
| 25 |
217791 |
Atropine Sulfate Ophthalmic Solution USP, 1% |
Somerset Therapeutics, LLC |
Isopto Atropine (Atropine Sulfate) Ophthalmic Solution |
4/29/2024 |
Indicated for mydriasis; cycloplegia; penalization of the healthy eye in the treatment of amblyopia |
| 24 |
216076 |
Midostaurin Capsules, 25 mg |
Teva Pharmaceuticals Development, Inc |
Rydapt (Midostaurin) Capsules |
4/29/2024 |
For the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive; for the treatment of adult patients with aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, or mast cell leukemia |
| 23 |
217813 |
Deflazacort Oral Suspension, 22.75 mg/mL |
Tris Pharma, Inc. |
Emflaza (Deflazacort) Oral Suspension |
4/25/2024 |
For the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older |
| 22 |
216160 |
Estradiol Gel, 0.06% |
Solaris Pharma Corporation |
EstroGel (Estradiol) Gel |
4/22/2024 |
For the treatment of moderate to severe vasomotor symptoms due to menopause; for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause |
| 21 |
216620 |
Eltrombopag for Oral Suspension, 12.5 mg and 25 mg |
Annora Pharma Private Limited |
Promacta (Eltrombopag) for Oral Suspension |
4/18/2024 |
For the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy; for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy; for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy |
| 20 |
203978 |
Nicardipine Hydrochloride in 0.83% Sodium Chloride Injection, 40 mg/200 mL (0.2 mg/mL), Single-Dose Containers and Nicardipine Hydrochloride in 0.86% Sodium Chloride Injection, 20 mg/200 mL (0.1 mg/mL), Single-Dose Containers |
InfoRLife SA |
Cardene (Nicardipine Hydrochloride) I.V. Premixed injection |
4/17/2024 |
For the short-term treatment of hypertension when oral therapy is not feasible |
| 19 |
218034 |
Doxycycline Capsules, 40 mg |
Dr. Reddy’s Laboratories Limited |
Oracea (Doxycycline) Capsules |
4/8/2024 |
For the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients |
| 18 |
216631 |
Doxycycline Capsules, 40 mg |
Lupin, Inc. |
Oracea (Doxycycline) Capsules |
4/8/2024 |
For the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients |
| 17 |
218047 |
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-dose Vial |
Gland Pharma Limited |
Halaven (Eribulin Mesylate) Injection |
4/5/2024 |
For the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease; unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen |
| 16 |
216064 |
Valbenazine Capsules, 40 mg, 60 mg, 80 mg |
Lupin Limited |
Ingrezza (Valbenazine) Capsules |
4/5/2024 |
For the treatment of adults with tardive dyskinesia |
| 15 |
216795 |
Metronidazole Vaginal Gel, 1.3% |
Encube Ethicals |
Nuvessa (Metronidazole) Vaginal Gel |
3/18/2024 |
For the treatment of bacterial vaginosis in females 12 years of age and older |
| 14 |
218232 |
Finasteride and Tadalafil Capsules, 5 mg/5 mg |
Zydus Worldwide DMCC |
Entadfi (Finasteride and Tadalafil) Capsules |
3/15/2024 |
To initiate treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate for up to 26 weeks |
| 13 |
216361 |
Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC) |
Dr. Reddy’s Laboratories SA |
Lumify (Brimonidine Tartrate) Ophthalmic Solution |
2/16/2024 |
Relieves redness of the eye due to minor eye irritations |
| 12 |
216103 |
Nitroglycerin Ointment USP, 0.4% |
Dr. Reddy’s Laboratories SA |
Rectiv (Nitroglycerin) Ointment |
2/16/2024 |
For the treatment of moderate to severe pain associated with chronic anal fissure |
| 11 |
215574 |
Ospemifene Tablets, 60 mg |
Hetero Labs Limited Unit V |
Osphena (Ospemifene) Tablets |
2/13/2024 |
For the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause; for the treatment of moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy, due to menopause |
| 10 |
217123 |
Deflazacort Tablets, 6 mg, 18 mg, 30 mg, and 36 mg |
Aurobindo Pharma Limited |
Emflaza (Deflazacort) Tablets |
2/9/2024 |
For the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older |
| 9 |
216899 |
Hydromorphone Hydrochloride Injection USP, 0.2 mg/mL, 0.5 mg/0.5 mL,1 mg/mL, 2 mg/mL Single-Dose Prefilled Syringes |
Hikma Pharmaceuticals USA, Inc. |
Dilaudid (Hydromorphone) Hydrochloride Injection |
2/9/2024 |
For the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate |
| 8 |
209986 |
Cobicistat Tablets, 150 mg |
Mylan Laboratories Limited |
Tybost (Cobicistat) Tablets |
2/4/2024 |
For the treatment of HIV-1 infection in adults and in pediatric patients |
| 7 |
211239 |
Bromfenac Ophthalmic Solution, 0.075% |
Lupin Limited |
BromSite (Bromfenac) Ophthalmic Solution |
2/2/2024 |
For the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery |
| 6 |
205904 |
Dronedarone Tablets USP, 400 mg |
Lupin Inc. |
Multaq (Dronedarone) Tablets |
1/31/2024 |
To reduce the risk of hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF |
| 5 |
214925 |
Pimavanserin Capsules, 34 mg |
MSN Laboratories Private Limited |
Nuplazid (Pimavanserin) Capsules |
1/16/2024 |
For the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis |
| 4 |
214502 |
Pimavanserin Tablets, 10 mg |
Zydus Pharmaceuticals (USA) Inc. |
Nuplazid (Pimavanserin) Capsules |
1/16/2024 |
For the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis |
| 3 |
214493 |
Pimavanserin Capsules, 34 mg |
Zydus Pharmaceuticals (USA) Inc. |
Nuplazid (Pimavanserin) Capsules |
1/16/2024 |
For the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis |
| 2 |
208443 |
Fidaxomicin Tablets, 200 mg |
Actavis Laboratories FL, Inc. |
Dificid (Fidaxomicin) Tablets |
1/16/2024 |
For the treatment of C. difficile-associated diarrhea |
| 1 |
203640 |
Nilotinib Capsules, 50 mg, 150 mg, 200 mg |
Apotex, Inc. |
Tasigna (Nilotinib) Capsules |
1/5/2024 |
For the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase; adult patients with chronic phase (CP) and accelerated phase (AP) Ph+ CML resistant to or intolerant to prior therapy that included imatinib; pediatric patients greater than or equal to 1 year of age with Ph+ CML-CP and CML-AP resistant or intolerant to prior tyrosine-kinase inhibitor therapy |
Source